$ALRTF
ALR Technologies SG Ltd. Stock $alrtf

$alrtf Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000190359623000359 Filed on May 01, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue		$2.367K	$5.360K
YoY Change		-68.3%
Cost Of Revenue		$1.176K	$1.170K
YoY Change		-53.39%
Gross Profit		$1.191K	$4.190K
YoY Change		-75.92%
Gross Profit Margin		50.32%	78.17%
Selling, General & Admin		$2.867M	$721.0K
YoY Change		83.06%
% of Gross Profit		240743.07%	17208.59%
Research & Development		$482.1K	$130.4K
YoY Change		-3.38%
% of Gross Profit		40482.03%	3110.98%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$3.349M	$851.4K
YoY Change		62.17%
Operating Profit		$4.270M	-$847.2K
YoY Change		44.91%
Interest Expense		$6.350M	-$2.666M
YoY Change		16.13%
% of Operating Profit		148.74%
Other Income/Expense, Net
YoY Change
Pretax Income			-$3.513M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings		-$10.62M	-$3.513M
YoY Change		25.77%
Net Earnings / Revenue		-448618.88%	-65542.16%
Basic Earnings Per Share
Diluted Earnings Per Share			-$0.01
COMMON SHARES
Basic Shares Outstanding	552.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$115.9K
YoY Change
Cash & Equivalents	$148.6K	$115.9K
Short-Term Investments
Other Short-Term Assets		$77.30K
YoY Change
Inventory
Prepaid Expenses	$228.7K	$77.30K
Receivables
Other Receivables
Total Short-Term Assets		$193.2K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		-$3.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets		$193.2K
Total Long-Term Assets		-$3.00
Total Assets	$377.3K	$193.2K
YoY Change	95.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.054M	$806.1K
YoY Change	30.8%
Accrued Expenses	$288.6K	$322.1K
YoY Change	-10.4%
Deferred Revenue
YoY Change
Short-Term Debt		$19.26M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$27.09M	$24.51M
YoY Change	10.54%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.09M	$24.51M
Total Long-Term Liabilities		$0.00
Total Liabilities	$28.93M	$24.51M
YoY Change	18.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$112.6M	-$102.0M
YoY Change	10.41%
Common Stock	$28.04M	$27.67M
YoY Change	1.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$28.55M	-$24.31M
YoY Change
Total Liabilities & Shareholders Equity	$377.3K	$193.2K
YoY Change	95.27%

Cashflow Statement

Concept	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$10.62M	-$3.513M
YoY Change	25.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$2.078M	-$1.768M
YoY Change	17.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$25.00
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.011M	1.829M
YoY Change	9.94%
NET CHANGE
Cash From Operating Activities	-$2.078M	-1.768M
Cash From Investing Activities
Cash From Financing Activities	$2.011M	1.829M
Net Change In Cash	$32.71K	61.14K
YoY Change	-34.24%
FREE CASH FLOW
Cash From Operating Activities	-$2.078M	-$1.768M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001930419
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2020	us-gaap	Revenues Revenues		usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	alrtf	Loss On Settlement Of Debt LossOnSettlementOfDebt		usd
CY2020	alrtf	Loss On Settlement Of Debt LossOnSettlementOfDebt		usd
CY2022	us-gaap	Other Income OtherIncome		usd
CY2021	us-gaap	Other Income OtherIncome		usd
CY2020	alrtf	Exchange Difference On Translating Foreign Operations ExchangeDifferenceOnTranslatingForeignOperations		usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross		usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts		usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash		usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash		usd
CY2022	alrtf	Write Off Of Accounts Payable WriteOffOfAccountsPayable		usd
CY2021	alrtf	Write Off Of Accounts Payable WriteOffOfAccountsPayable		usd
CY2021	alrtf	Interest Accretion On Loan Payable InterestAccretionOnLoanPayable		usd
CY2020	alrtf	Interest Accretion On Loan Payable InterestAccretionOnLoanPayable		usd
CY2021	alrtf	Borrowing Costs On Non Current Loan Payable BorrowingCostsOnNonCurrentLoanPayable		usd
CY2020	alrtf	Borrowing Costs On Non Current Loan Payable BorrowingCostsOnNonCurrentLoanPayable		usd
CY2021	alrtf	Bonuses Settled By Issuance Of Shares BonusesSettledByIssuanceOfShares		usd
CY2020	alrtf	Bonuses Settled By Issuance Of Shares BonusesSettledByIssuanceOfShares		usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
CY2020	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Proceeds From Issuance Of Financial Services Obligations ProceedsFromIssuanceOfFinancialServicesObligations		usd
CY2021	us-gaap	Proceeds From Issuance Of Financial Services Obligations ProceedsFromIssuanceOfFinancialServicesObligations		usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2022	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties		usd
CY2021	alrtf	Options Exchanged For Warrants Upon Redomicile Merger OptionsExchangedForWarrantsUponRedomicileMerger		shares
CY2021	alrtf	Options Exchanged For Warrants Upon Redomicile Mergerweightageaverage OptionsExchangedForWarrantsUponRedomicileMergerweightageaverage
CY2020	alrtf	Options Exchanged For Warrants Upon Redomicile Merger OptionsExchangedForWarrantsUponRedomicileMerger		shares
CY2020	alrtf	Options Exchanged For Warrants Upon Redomicile Mergerweightageaverage OptionsExchangedForWarrantsUponRedomicileMergerweightageaverage
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet		usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding		shares
CY2022	alrtf	Weighted Average Exercise Price Beginnings WeightedAverageExercisePriceBeginnings
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding		shares
CY2021	alrtf	Weighted Average Exercise Price Beginnings WeightedAverageExercisePriceBeginnings
CY2021	alrtf	Options Exchanged For Warrants OptionsExchangedForWarrants		shares
CY2021	alrtf	Weighted Average Exercise Price Warrant Outstanding WeightedAverageExercisePriceWarrantOutstanding
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding		shares
CY2021	alrtf	Weighted Average Exercise Price Endings WeightedAverageExercisePriceEndings
CY2021	alrtf	Warrants Exercisable WarrantsExercisable		shares
CY2021	alrtf	Weighted Average Exercise Price Exercisable Endings WeightedAverageExercisePriceExercisableEndings
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued		shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2021	alrtf	Intrinsic Values IntrinsicValues
CY2021	alrtf	Interest Expenses On Loan Payable To Company Controlled By Vp And Immediate Family Members InterestExpensesOnLoanPayableToCompanyControlledByVpAndImmediateFamilyMembers		usd
CY2020	alrtf	Interest Expenses On Loan Payable To Company Controlled By Vp And Immediate Family Members InterestExpensesOnLoanPayableToCompanyControlledByVpAndImmediateFamilyMembers		usd
CY2021	alrtf	Borrowing Costs Recorded In Interest Expense On Loan Payable To Company Controlled By Vp And Immediate Family Members BorrowingCostsRecordedInInterestExpenseOnLoanPayableToCompanyControlledByVpAndImmediateFamilyMembers		usd
CY2020	alrtf	Borrowing Costs Recorded In Interest Expense On Loan Payable To Company Controlled By Vp And Immediate Family Members BorrowingCostsRecordedInInterestExpenseOnLoanPayableToCompanyControlledByVpAndImmediateFamilyMembers		usd
CY2020	alrtf	Interest Expense Related To Grant Andor Modification Of Stock Options Held By Ceo And Vp Of Company Related To Financing Provided InterestExpenseRelatedToGrantAndorModificationOfStockOptionsHeldByCeoAndVpOfCompanyRelatedToFinancingProvided		usd
CY2022	alrtf	Interest Expense Related To Stock Options Granted To Vp Of Company Related To Increase Of Borrowing Limit Of Line Of Credit InterestExpenseRelatedToStockOptionsGrantedToVpOfCompanyRelatedToIncreaseOfBorrowingLimitOfLineOfCredit		usd
CY2020	alrtf	Interest Expense Related To Stock Options Granted To Vp Of Company Related To Increase Of Borrowing Limit Of Line Of Credit InterestExpenseRelatedToStockOptionsGrantedToVpOfCompanyRelatedToIncreaseOfBorrowingLimitOfLineOfCredit		usd
CY2021	alrtf	Salary And Bonus Paid To Ceo Of Company SalaryAndBonusPaidToCeoOfCompany		usd
CY2020	alrtf	Salary And Bonus Paid To Ceo Of Company SalaryAndBonusPaidToCeoOfCompany		usd
CY2021	alrtf	Bonus To Director Of Company Settled With Issuance Of Ordinary Shares BonusToDirectorOfCompanySettledWithIssuanceOfOrdinaryShares		usd
CY2020	alrtf	Bonus To Director Of Company Settled With Issuance Of Ordinary Shares BonusToDirectorOfCompanySettledWithIssuanceOfOrdinaryShares		usd
CY2020	alrtf	Salary For Services To Vp Of Company SalaryForServicesToVpOfCompany		usd
CY2021	alrtf	Salary For Services As Secretary And Chief Legal Counsel Of Company SalaryForServicesAsSecretaryAndChiefLegalCounselOfCompany		usd
CY2020	alrtf	Salary For Services As Secretary And Chief Legal Counsel Of Company SalaryForServicesAsSecretaryAndChiefLegalCounselOfCompany		usd
CY2021	alrtf	Selling General And Administration Expense Related To Stock Options Granted To Chief Legal Counsel Of Company SellingGeneralAndAdministrationExpenseRelatedToStockOptionsGrantedToChiefLegalCounselOfCompany		usd
CY2020	alrtf	Selling General And Administration Expense Related To Stock Options Granted To Chief Legal Counsel Of Company SellingGeneralAndAdministrationExpenseRelatedToStockOptionsGrantedToChiefLegalCounselOfCompany		usd
CY2022	alrtf	Loss On Settlement Of Debt To Relative Of Ceo Of Company LossOnSettlementOfDebtToRelativeOfCeoOfCompany		usd
CY2020	alrtf	Loss On Settlement Of Debt To Relative Of Ceo Of Company LossOnSettlementOfDebtToRelativeOfCeoOfCompany		usd
CY2020	alrtf	Rent Paid To Company Controlled By Vp And Immediate Family Members RentPaidToCompanyControlledByVpAndImmediateFamilyMembers		usd
CY2022	alrtf	Stock Options Granted To Member Of Board Of Directors Of Company StockOptionsGrantedToMemberOfBoardOfDirectorsOfCompany		usd
CY2020	alrtf	Stock Options Granted To Member Of Board Of Directors Of Company StockOptionsGrantedToMemberOfBoardOfDirectorsOfCompany		usd
CY2022	alrtf	Income Tax Provision IncomeTaxProvision		usd
CY2021	alrtf	Income Tax Provision IncomeTaxProvision		usd
CY2020	alrtf	Income Tax Provision IncomeTaxProvision		usd
CY2022	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes		usd
CY2021	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes		usd
CY2020	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes		usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022	alrtf	Ordinary Shares Issued To Retire Interest Payable And Promissory Notes Payable OrdinarySharesIssuedToRetireInterestPayableAndPromissoryNotesPayable		usd
CY2022	alrtf	Ordinary Shares Issued To Retire Line Of Credit OrdinarySharesIssuedToRetireLineOfCredit		usd
CY2021	alrtf	Ordinary Shares Issued To Retire Line Of Credit OrdinarySharesIssuedToRetireLineOfCredit		usd
CY2022	alrtf	Reclassification Of Additional Paidin Capital On Exercise Of Stock Options ReclassificationOfAdditionalPaidinCapitalOnExerciseOfStockOptions		usd
CY2020	alrtf	Reclassification Of Additional Paidin Capital On Exercise Of Stock Options ReclassificationOfAdditionalPaidinCapitalOnExerciseOfStockOptions		usd
CY2021	alrtf	Additional Paidin Capital On Kwc Loan Payable AdditionalPaidinCapitalOnKwcLoanPayable		usd
CY2020	alrtf	Additional Paidin Capital On Kwc Loan Payable AdditionalPaidinCapitalOnKwcLoanPayable		usd
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56491
CY2022	dei	Entity Registrant Name EntityRegistrantName	ALR Technologies SG Ltd.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	U0
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	80 Robinson Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	#02-00
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Singapore
CY2022	dei	Entity Address Country EntityAddressCountry	SG
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	068898
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	551966844	shares
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Name AuditorName	DALE MATHESON CARR-HILTON LABONTE LLP
CY2022	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2022	dei	Auditor Firm AuditorFirmId	1173
CY2022Q4	us-gaap	Cash Cash	148628	usd
CY2021Q4	us-gaap	Cash Cash	115922	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	228661	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	77295	usd
CY2022Q4	us-gaap	Assets Assets	377289	usd
CY2021Q4	us-gaap	Assets Assets	193217	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1342872	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1130546	usd
CY2022Q4	alrtf	Notes Payable Related Parties Classified Current One NotesPayableRelatedPartiesClassifiedCurrentOne	3091966	usd
CY2021Q4	alrtf	Notes Payable Related Parties Classified Current One NotesPayableRelatedPartiesClassifiedCurrentOne	3041966	usd
CY2022Q4	alrtf	Notes Payable Related Un Parties Classified Current NotesPayableRelatedUnPartiesClassifiedCurrent	2163368	usd
CY2021Q4	alrtf	Notes Payable Related Un Parties Classified Current NotesPayableRelatedUnPartiesClassifiedCurrent	2213368	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4662731	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4110647	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	15828155	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	14008833	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27089092	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24505360	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1842982	usd
CY2022Q4	us-gaap	Liabilities Liabilities	28932074	usd
CY2021Q4	us-gaap	Liabilities Liabilities	24505360	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	551966844	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	551966844	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	542716344	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	542716344	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	28040825	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	27670800	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56032129	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50043543	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6147	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11409	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-112633886	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102015077	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28554785	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-24312143	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	377289	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	193217	usd
CY2022	us-gaap	Revenues Revenues	2367	usd
CY2021	us-gaap	Revenues Revenues	7468	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1176	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	2523	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	482141	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	498996	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1433027	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	920208	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	881016	usd
CY2020	us-gaap	Professional Fees ProfessionalFees	953350	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2867250	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1566306	usd
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1439634	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	4269599	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	2946318	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	3826011	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-4268408	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2941373	usd
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3826011	usd
CY2022	us-gaap	Interest Expense InterestExpense	6350401	usd
CY2021	us-gaap	Interest Expense InterestExpense	5468328	usd
CY2020	us-gaap	Interest Expense InterestExpense	2116466	usd
CY2021	alrtf	Loss On Settlement Of Debt LossOnSettlementOfDebt	-33614	usd
CY2020	us-gaap	Other Income OtherIncome	26460	usd
CY2022	alrtf	Other Items Amount OtherItemsAmount	-6350401	usd
CY2021	alrtf	Other Items Amount OtherItemsAmount	-5501942	usd
CY2020	alrtf	Other Items Amount OtherItemsAmount	-2090006	usd
CY2022	alrtf	Net Loss NetLoss	-10618809	usd
CY2021	alrtf	Net Loss NetLoss	-8443315	usd
CY2020	alrtf	Net Loss NetLoss	-5916017	usd
CY2022	alrtf	Exchange Difference On Translating Foreign Operations ExchangeDifferenceOnTranslatingForeignOperations	17556	usd
CY2021	alrtf	Exchange Difference On Translating Foreign Operations ExchangeDifferenceOnTranslatingForeignOperations	-11409	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-10601253	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-8454724	usd
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-5916017	usd
CY2022	alrtf	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	548078686	shares
CY2021	alrtf	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	534980347	shares
CY2020	alrtf	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	337033584	shares
CY2022	alrtf	Loss Per Share Basic And Diluted LossPerShareBasicAndDiluted	-0.02
CY2021	alrtf	Loss Per Share Basic And Diluted LossPerShareBasicAndDiluted	-0.02
CY2020	alrtf	Loss Per Share Basic And Diluted LossPerShareBasicAndDiluted	-0.02
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-31088266	usd
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12080000	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12140	usd
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	200000	usd
CY2020	alrtf	Imputed Interest ImputedInterest	123518	usd
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2828017	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5916017	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-21760608	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	250800	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1124832	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	usd
CY2021	alrtf	Imputed Interest ImputedInterest	112339	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4403218	usd
CY2021	alrtf	Exchange Difference On Translating Foreign Operations ExchangeDifferenceOnTranslatingForeignOperations	-11409	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8443315	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-24312143	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-24312143	usd
CY2022	alrtf	Issuance Of Ordinary Shares For Settlement Of Debt And Bonuses IssuanceOfOrdinarySharesForSettlementOfDebtAndBonuses	370000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25	usd
CY2022	alrtf	Imputed Interest ImputedInterest	104494	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	5770180	usd
CY2022	alrtf	Exchange Difference On Translating Foreign Operations ExchangeDifferenceOnTranslatingForeignOperations	17556	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10618809	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-28554785	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10618809	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8443315	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5916017	usd
CY2022	alrtf	Share Based Compensation Product Development Costs ShareBasedCompensationProductDevelopmentCosts	227338	usd
CY2021	alrtf	Share Based Compensation Product Development Costs ShareBasedCompensationProductDevelopmentCosts	222178	usd
CY2020	alrtf	Share Based Compensation Product Development Costs ShareBasedCompensationProductDevelopmentCosts	1156195	usd
CY2022	alrtf	Share Based Compensation Selling General And Administration ShareBasedCompensationSellingGeneralAndAdministration	1499322	usd
CY2021	alrtf	Share Based Compensation Selling General And Administration ShareBasedCompensationSellingGeneralAndAdministration	586538	usd
CY2020	alrtf	Share Based Compensation Selling General And Administration ShareBasedCompensationSellingGeneralAndAdministration	930258	usd
CY2022	alrtf	Share Based Compensation Professional Fees ShareBasedCompensationProfessionalFees	38614	usd
CY2021	alrtf	Share Based Compensation Professional Fees ShareBasedCompensationProfessionalFees	169382	usd
CY2020	alrtf	Share Based Compensation Professional Fees ShareBasedCompensationProfessionalFees	741564	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4004906	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3425120	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	1596667	usd
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	1402187	usd
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	1464077	usd
CY2022	alrtf	Non Cash Imputed Interest Expense NonCashImputedInterestExpense	104494	usd
CY2021	alrtf	Non Cash Imputed Interest Expense NonCashImputedInterestExpense	112339	usd
CY2020	alrtf	Non Cash Imputed Interest Expense NonCashImputedInterestExpense	123518	usd
CY2020	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	20000	usd
CY2020	alrtf	Write Off Of Accounts Payable WriteOffOfAccountsPayable	-26460	usd
CY2022	alrtf	Interest Accretion On Loan Payable InterestAccretionOnLoanPayable	23315	usd
CY2022	alrtf	Borrowing Costs On Non Current Loan Payable BorrowingCostsOnNonCurrentLoanPayable	72834	usd
CY2022	alrtf	Bonuses Settled By Issuance Of Shares BonusesSettledByIssuanceOfShares	245000	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	33614	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-151366	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-14636	usd
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-62659	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	337326	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	211012	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	72099	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	542834	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	527336	usd
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	528871	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2077525	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1768245	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-968554	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	727986	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1149279	usd
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	820766	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	649708	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	1779250	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	496081	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	456725	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	649708	usd
CY2020	us-gaap	Proceeds From Issuance Of Financial Services Obligations ProceedsFromIssuanceOfFinancialServicesObligations	200000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1136832	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12140	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2011180	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1829386	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1032906	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	99051	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-11409	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32706	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49732	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	64352	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115922	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66190	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1838	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148628	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115922	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66190	usd
CY2022	alrtf	Promissory Notes Received PromissoryNotesReceived	405350	usd
CY2022	alrtf	Repayment Of Promissory Notes RepaymentOfPromissoryNotes	-405350	usd
CY2022	alrtf	Transferred From Promissory Notes Payable Pursuant To Private Transaction One TransferredFromPromissoryNotesPayablePursuantToPrivateTransactionOne	50000	usd
CY2022Q4	alrtf	Notes Payable Related Parties Classified Current One NotesPayableRelatedPartiesClassifiedCurrentOne	3091966	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.043
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zcOG8SDniiah" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <span id="xdx_864_zIn9QwPaqz7b">Use of estimates</span></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, the measurement of share-based compensation, the fair value of financial instruments, the fair value of loan payable, and the reported amounts of revenues and expenses during the reporting period. Management believes the estimates are reasonable; however, actual results could differ from those estimates.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1054285	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	806059	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	288587	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	322087	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2400	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1342872	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1130546	usd
CY2019Q4	alrtf	Notes Payable Related Parties Classified Current One NotesPayableRelatedPartiesClassifiedCurrentOne	3031966	usd
CY2020Q4	alrtf	Notes Payable Related Parties Classified Current One NotesPayableRelatedPartiesClassifiedCurrentOne	3041966	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	3091966	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	3041966	usd
CY2021	alrtf	Promissory Notes Payable Unrelated Parties Beginning PromissoryNotesPayableUnrelatedPartiesBeginning	2254353	usd
CY2021	alrtf	Reclassified To Interest Payable ReclassifiedToInterestPayable	-10985	usd
CY2021	alrtf	Extinguished Through Issuance Of Ordinary Shares ExtinguishedThroughIssuanceOfOrdinaryShares	-20000	usd
CY2021	alrtf	Transferred From Promissory Notes Payable Pursuant To Private Transaction Two TransferredFromPromissoryNotesPayablePursuantToPrivateTransactionTwo	-10000	usd
CY2022	alrtf	Promissory Notes Payable Unrelated Parties Begining PromissoryNotesPayableUnrelatedPartiesBegining	2213368	usd
CY2022	alrtf	Promissory Notes Received One PromissoryNotesReceivedOne	244358	usd
CY2022	alrtf	Repayment Of Promissory Notes One RepaymentOfPromissoryNotesOne	-244358	usd
CY2022	alrtf	Transferred From Promissory Notes Payable Pursuant To Private Transaction Three TransferredFromPromissoryNotesPayablePursuantToPrivateTransactionThree	-50000	usd
CY2022	alrtf	Promissory Notes Payable Unrelated Parties Ending PromissoryNotesPayableUnrelatedPartiesEnding	2163368	usd
CY2022Q4	alrtf	Promissory Note Payable PromissoryNotePayable	2163368	usd
CY2021Q4	alrtf	Promissory Note Payable PromissoryNotePayable	2213368	usd
CY2022	alrtf	Options Exchanged For Warrants Upon Redomicile Mergerweightageaverage OptionsExchangedForWarrantsUponRedomicileMergerweightageaverage	-0.004
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	800000	shares
CY2020Q4	alrtf	Interest Payable Begining Balance InterestPayableBeginingBalance	3575326	usd
CY2021	alrtf	Reclassified From Promissory Notes Payable ReclassifiedFromPromissoryNotesPayable	10985	usd
CY2021	alrtf	Interest Incurred On Promissory Notes Payable InterestIncurredOnPromissoryNotesPayable	527336	usd
CY2021	alrtf	Interest Payable Retired Through Issuance Of Shares InterestPayableRetiredThroughIssuanceOfShares	-3000	usd
CY2021Q4	alrtf	Interest Payable Begining Balance InterestPayableBeginingBalance	4110647	usd
CY2022	alrtf	Interest Incurred On Promissory Notes Payable InterestIncurredOnPromissoryNotesPayable	542834	usd
CY2022	alrtf	Transferred From Lines Of Credit Interest TransferredFromLinesOfCreditInterest	9250	usd
CY2022Q4	alrtf	Interest Payable Begining Balance InterestPayableBeginingBalance	4662731	usd
CY2022Q4	alrtf	Related Parties Payable RelatedPartiesPayable	1534006	usd
CY2021Q4	alrtf	Related Parties Payable RelatedPartiesPayable	1200170	usd
CY2022Q4	alrtf	Unrelated Parties Payable UnrelatedPartiesPayable	3128725	usd
CY2021Q4	alrtf	Unrelated Parties Payable UnrelatedPartiesPayable	2910477	usd
CY2022Q4	alrtf	Interest Payable Net InterestPayableNet	4662731	usd
CY2021Q4	alrtf	Interest Payable Net InterestPayableNet	4110647	usd
CY2022	us-gaap	Proceeds From Loans ProceedsFromLoans	1779250	usd
CY2022	alrtf	Proceeds Allocated To Additional Paidin Capital As Benefit ProceedsAllocatedToAdditionalPaidinCapitalAsBenefit	-113912	usd
CY2022	us-gaap	Interest Paid InterestPaid	23315	usd
CY2022	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	72834	usd
CY2022	us-gaap	Unrealized Gain On Foreign Currency Derivatives Before Tax UnrealizedGainOnForeignCurrencyDerivativesBeforeTax	81495	usd
CY2022	alrtf	Increase Decrease In Notes Payable Related Parties One IncreaseDecreaseInNotesPayableRelatedPartiesOne	1842982	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.015
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	90300000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.040
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	29900000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.034
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	13500000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.034
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	321700000	shares
CY2020Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	11914092	usd
CY2021	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	1149279	usd
CY2021	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	1402187	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	456725	usd
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	14008833	usd
CY2022	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	727986	usd
CY2022	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	1596667	usd
CY2022	alrtf	Interest Transferred To Promissory Notes Interest Payable InterestTransferredToPromissoryNotesInterestPayable	-9250	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	496081	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	15828155	usd
CY2022Q4	alrtf	Borrowing Limit BorrowingLimit	14300000	usd
CY2022Q4	alrtf	Principal Borrowed PrincipalBorrowed	13416391	usd
CY2022Q4	alrtf	Accuredinterest Accuredinterest	2411764	usd
CY2022Q4	alrtf	Outstanding Amount OutstandingAmount	15828155	usd
CY2021Q4	alrtf	Borrowing Limit BorrowingLimit	14300000	usd
CY2021Q4	alrtf	Principal Borrowed PrincipalBorrowed	12688405	usd
CY2021Q4	alrtf	Accuredinterest Accuredinterest	1320428	usd
CY2021Q4	alrtf	Outstanding Amount OutstandingAmount	14008833	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5497001500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.006
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5362701500	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.004
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5236401500	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.003
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	115500000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.050
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	165000000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.050
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	139800000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.047
CY2022	alrtf	Options Exchanged For Warrants Upon Redomicile Merger OptionsExchangedForWarrantsUponRedomicileMerger	-5200501500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5497001500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.006
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5362701500	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.004
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease	160800000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.037
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease	5221701500	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.004
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease	5202701500	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.003
CY2022	alrtf	Options Outstanding OptionsOutstanding	321700000	shares
CY2022	alrtf	Exercise Prices ExercisePrices	0.043
CY2022	alrtf	Intrinsic Value IntrinsicValue	0.022
CY2021	alrtf	Options Outstanding OptionsOutstanding	5497001500	shares
CY2021	alrtf	Exercise Prices ExercisePrices	0.006
CY2021	alrtf	Intrinsic Value IntrinsicValue	0.054
CY2020	alrtf	Options Outstanding OptionsOutstanding	5362701500	shares
CY2020	alrtf	Exercise Prices ExercisePrices	0.004
CY2020	alrtf	Intrinsic Value IntrinsicValue	0.066
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M15D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y4M13D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y18D
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4004906	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	3425120	usd
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	227338	usd
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	222178	usd
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1156195	usd
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	38614	usd
CY2021	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	169382	usd
CY2020	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	741564	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	1499322	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	586538	usd
CY2020	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	930258	usd
CY2022	alrtf	Income Expense Net IncomeExpenseNet	5770180	usd
CY2021	alrtf	Income Expense Net IncomeExpenseNet	4403218	usd
CY2020	alrtf	Income Expense Net IncomeExpenseNet	2828017	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0305	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0087	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0020	pure
CY2022	alrtf	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm
CY2021	alrtf	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm
CY2020	alrtf	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.23	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.78	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.12	pure
CY2022	alrtf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Forfeture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateForfetureRate	0	pure
CY2021	alrtf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Forfeture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateForfetureRate	0	pure
CY2020	alrtf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Forfeture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateForfetureRate	0	pure
CY2022	alrtf	Options Exchanged For Warrants OptionsExchangedForWarrants	5200501500	shares
CY2022	alrtf	Weighted Average Exercise Price Warrant Outstanding WeightedAverageExercisePriceWarrantOutstanding	0.004
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5200501500	shares
CY2022	alrtf	Weighted Average Exercise Price Endings WeightedAverageExercisePriceEndings	0.004
CY2022	alrtf	Warrants Exercisable WarrantsExercisable	5200501500	shares
CY2022	alrtf	Weighted Average Exercise Price Exercisable Endings WeightedAverageExercisePriceExercisableEndings	0.004
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5200501500	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.004
CY2022	alrtf	Intrinsic Values IntrinsicValues	0.061
CY2022	alrtf	Interest Expense On Promissory Notes Issued To Relatives Of Ceo Of Company InterestExpenseOnPromissoryNotesIssuedToRelativesOfCeoOfCompany	324586	usd
CY2021	alrtf	Interest Expense On Promissory Notes Issued To Relatives Of Ceo Of Company InterestExpenseOnPromissoryNotesIssuedToRelativesOfCeoOfCompany	316504	usd
CY2020	alrtf	Interest Expense On Promissory Notes Issued To Relatives Of Ceo Of Company InterestExpenseOnPromissoryNotesIssuedToRelativesOfCeoOfCompany	315926	usd
CY2022	alrtf	Interest Expenses On Loan Payable To Company Controlled By Vp And Immediate Family Members InterestExpensesOnLoanPayableToCompanyControlledByVpAndImmediateFamilyMembers	23315	usd
CY2022	alrtf	Borrowing Costs Recorded In Interest Expense On Loan Payable To Company Controlled By Vp And Immediate Family Members BorrowingCostsRecordedInInterestExpenseOnLoanPayableToCompanyControlledByVpAndImmediateFamilyMembers	72834	usd
CY2022	alrtf	Interest Expense On Lines Of Credit Payable To Ceo And Vp Of Company InterestExpenseOnLinesOfCreditPayableToCeoAndVpOfCompany	1596667	usd
CY2021	alrtf	Interest Expense On Lines Of Credit Payable To Ceo And Vp Of Company InterestExpenseOnLinesOfCreditPayableToCeoAndVpOfCompany	1402187	usd
CY2020	alrtf	Interest Expense On Lines Of Credit Payable To Ceo And Vp Of Company InterestExpenseOnLinesOfCreditPayableToCeoAndVpOfCompany	1464077	usd
CY2022	alrtf	Interest Expense Related To Grant Andor Modification Of Stock Options Held By Ceo And Vp Of Company Related To Financing Provided InterestExpenseRelatedToGrantAndorModificationOfStockOptionsHeldByCeoAndVpOfCompanyRelatedToFinancingProvided	4004906	usd
CY2021	alrtf	Interest Expense Related To Grant Andor Modification Of Stock Options Held By Ceo And Vp Of Company Related To Financing Provided InterestExpenseRelatedToGrantAndorModificationOfStockOptionsHeldByCeoAndVpOfCompanyRelatedToFinancingProvided	1287834	usd
CY2021	alrtf	Interest Expense Related To Stock Options Granted To Vp Of Company Related To Increase Of Borrowing Limit Of Line Of Credit InterestExpenseRelatedToStockOptionsGrantedToVpOfCompanyRelatedToIncreaseOfBorrowingLimitOfLineOfCredit	2137286	usd
CY2022	alrtf	Consulting Fees To Ceo Of Company Accrued On Line Of Credit Available To Company ConsultingFeesToCeoOfCompanyAccruedOnLineOfCreditAvailableToCompany	124800	usd
CY2021	alrtf	Consulting Fees To Ceo Of Company Accrued On Line Of Credit Available To Company ConsultingFeesToCeoOfCompanyAccruedOnLineOfCreditAvailableToCompany	249600	usd
CY2020	alrtf	Consulting Fees To Ceo Of Company Accrued On Line Of Credit Available To Company ConsultingFeesToCeoOfCompanyAccruedOnLineOfCreditAvailableToCompany	249600	usd
CY2022	alrtf	Salary And Bonus Paid To Ceo Of Company SalaryAndBonusPaidToCeoOfCompany	274800	usd
CY2022	alrtf	Bonus To Director Of Company Settled With Issuance Of Ordinary Shares BonusToDirectorOfCompanySettledWithIssuanceOfOrdinaryShares	40000	usd
CY2022	alrtf	Salary For Services To Vp Of Company SalaryForServicesToVpOfCompany	43532	usd
CY2021	alrtf	Salary For Services To Vp Of Company SalaryForServicesToVpOfCompany	33427	usd
CY2022	alrtf	Salary For Services As Secretary And Chief Legal Counsel Of Company SalaryForServicesAsSecretaryAndChiefLegalCounselOfCompany	8706	usd
CY2022	alrtf	Selling General And Administration Expense Related To Stock Options Granted To Chief Legal Counsel Of Company SellingGeneralAndAdministrationExpenseRelatedToStockOptionsGrantedToChiefLegalCounselOfCompany	304291	usd
CY2021	alrtf	Loss On Settlement Of Debt To Relative Of Ceo Of Company LossOnSettlementOfDebtToRelativeOfCeoOfCompany	16800	usd
CY2022	alrtf	Rent Paid To Company Controlled By Vp And Immediate Family Members RentPaidToCompanyControlledByVpAndImmediateFamilyMembers	20206	usd
CY2021	alrtf	Rent Paid To Company Controlled By Vp And Immediate Family Members RentPaidToCompanyControlledByVpAndImmediateFamilyMembers	24390	usd
CY2021	alrtf	Stock Options Granted To Member Of Board Of Directors Of Company StockOptionsGrantedToMemberOfBoardOfDirectorsOfCompany	304692	usd
CY2022	alrtf	Computed Expected Benefit Of Income Taxes ComputedExpectedBenefitOfIncomeTaxes	-2229950	usd
CY2021	alrtf	Computed Expected Benefit Of Income Taxes ComputedExpectedBenefitOfIncomeTaxes	-1773096	usd
CY2020	alrtf	Computed Expected Benefit Of Income Taxes ComputedExpectedBenefitOfIncomeTaxes	-1242363	usd
CY2022	alrtf	Sharebased Compensation And Permanent Differences SharebasedCompensationAndPermanentDifferences	1220577	usd
CY2021	alrtf	Sharebased Compensation And Permanent Differences SharebasedCompensationAndPermanentDifferences	925449	usd
CY2020	alrtf	Sharebased Compensation And Permanent Differences SharebasedCompensationAndPermanentDifferences	593885	usd
CY2022	alrtf	Nondeductible Interest Expense NondeductibleInterestExpense	364680	usd
CY2021	alrtf	Nondeductible Interest Expense NondeductibleInterestExpense	334556	usd
CY2020	alrtf	Nondeductible Interest Expense NondeductibleInterestExpense	79418	usd
CY2022	alrtf	Expiry Of Tax Credits ExpiryOfTaxCredits	525830	usd
CY2021	alrtf	Expiry Of Tax Credits ExpiryOfTaxCredits	773050	usd
CY2020	alrtf	Expiry Of Tax Credits ExpiryOfTaxCredits	929432	usd
CY2022	alrtf	True Up Of Prior Year Balances TrueUpOfPriorYearBalances	-30092	usd
CY2021	alrtf	True Up Of Prior Year Balances TrueUpOfPriorYearBalances	99348	usd
CY2020	alrtf	True Up Of Prior Year Balances TrueUpOfPriorYearBalances	1214608	usd
CY2022	alrtf	Increase Decrease In Valuation Allowance IncreaseDecreaseInValuationAllowance	148955	usd
CY2021	alrtf	Increase Decrease In Valuation Allowance IncreaseDecreaseInValuationAllowance	-359307	usd
CY2020	alrtf	Increase Decrease In Valuation Allowance IncreaseDecreaseInValuationAllowance	-1574980	usd
CY2022	alrtf	Net Operating Loss Carried Forward NetOperatingLossCarriedForward	36124160	usd
CY2021	alrtf	Net Operating Loss Carried Forward NetOperatingLossCarriedForward	35414853	usd
CY2020	alrtf	Net Operating Loss Carried Forward NetOperatingLossCarriedForward	37125837	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	7586074	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	7437119	usd
CY2020	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	7796426	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-7586074	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-7437119	usd
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-7796426	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	36124000	usd
CY2022Q4	alrtf	Current And Noncurrent Asset CurrentAndNoncurrentAsset	377289	usd
CY2021Q4	alrtf	Current And Noncurrent Asset CurrentAndNoncurrentAsset	193217	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2367	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7468	usd
CY2022	alrtf	Net Loss NetLoss	-10618809	usd
CY2021	alrtf	Net Loss NetLoss	-8443315	usd
CY2020	alrtf	Net Loss NetLoss	-5916017	usd
CY2022	alrtf	Ordinary Shares Issued To Retire Accounts Payable OrdinarySharesIssuedToRetireAccountsPayable	125000	usd
CY2021	alrtf	Ordinary Shares Issued To Retire Accounts Payable OrdinarySharesIssuedToRetireAccountsPayable	194186	usd
CY2020	alrtf	Ordinary Shares Issued To Retire Accounts Payable OrdinarySharesIssuedToRetireAccountsPayable	60000	usd
CY2021	alrtf	Ordinary Shares Issued To Retire Interest Payable And Promissory Notes Payable OrdinarySharesIssuedToRetireInterestPayableAndPromissoryNotesPayable	23000	usd
CY2020	alrtf	Ordinary Shares Issued To Retire Interest Payable And Promissory Notes Payable OrdinarySharesIssuedToRetireInterestPayableAndPromissoryNotesPayable	2318542	usd
CY2020	alrtf	Ordinary Shares Issued To Retire Line Of Credit OrdinarySharesIssuedToRetireLineOfCredit	9681458	usd
CY2021	alrtf	Reclassification Of Additional Paidin Capital On Exercise Of Stock Options ReclassificationOfAdditionalPaidinCapitalOnExerciseOfStockOptions	41271	usd
CY2022	alrtf	Additional Paidin Capital On Kwc Loan Payable AdditionalPaidinCapitalOnKwcLoanPayable	113912	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001903596-23-000359-index-headers.html	Edgar Link	pending
0001903596-23-000359-index.html	Edgar Link	pending
0001903596-23-000359.txt	Edgar Link	pending
0001903596-23-000359-xbrl.zip	Edgar Link	pending
alr-001.jpg	Edgar Link	pending
alr-002.jpg	Edgar Link	pending
alrtf-20221231.xsd	Edgar Link	pending
alr_20f.htm	Edgar Link	pending
ex10_1.htm	Edgar Link	pending
ex10_2-001.jpg	Edgar Link	pending
ex10_2-002.jpg	Edgar Link	pending
ex10_2-003.jpg	Edgar Link	pending
ex10_2-004.jpg	Edgar Link	pending
ex10_2-005.jpg	Edgar Link	pending
ex10_2-006.jpg	Edgar Link	pending
alrtf-20221231_pre.xml	Edgar Link	unprocessable
alrtf-20221231_cal.xml	Edgar Link	unprocessable
alrtf-20221231_lab.xml	Edgar Link	unprocessable
alrtf-20221231_def.xml	Edgar Link	unprocessable
alr_20f_htm.xml	Edgar Link	completed
ex10_2-007.jpg	Edgar Link	pending
ex10_2-008.jpg	Edgar Link	pending
ex10_2.htm	Edgar Link	pending
ex10_3.htm	Edgar Link	pending
ex10_4.htm	Edgar Link	pending
ex10_4.jpg	Edgar Link	pending
ex10_5.htm	Edgar Link	pending
ex10_6.htm	Edgar Link	pending
ex10_7.htm	Edgar Link	pending
ex14_1.htm	Edgar Link	pending
ex21_1.htm	Edgar Link	pending
ex2_1.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex3_1.htm	Edgar Link	pending
ex4_1-001.jpg	Edgar Link	pending
ex4_1.htm	Edgar Link	pending
ex4_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALRTF
ALR Technologies SG Ltd. Stock $alrtf

2022 Q4 Form 20-F Financial Statement

#000190359623000359 Filed on May 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALRTF ALR Technologies SG Ltd. Stock $alrtf

2022 Q4 Form 20-F Financial Statement

#000190359623000359 Filed on May 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALRTF
ALR Technologies SG Ltd. Stock $alrtf